Gamma globulin 1 cc inj
Products billed under this code include Gamastan.
Payment limit per 1 CC, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Gamastan.
Payment limit per 1 CC, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Gamastan | Grifols USA, LLC | 13533-0335-04 | 2 | $97.892 |
| Gamastan | Grifols USA, LLC | 13533-0335-12 | 10 | $489.46 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $48.946 | +$0.072 | 1 CC | Gamma globulin 1 cc inj | v1, posted September 17, 2026 |
| 3Q26 | $48.874 | −$0.079 | 1 CC | Gamma globulin 1 cc inj | v1, posted September 15, 2026 |
| 2Q26 | $48.953 | −$0.97 | 1 CC | Gamma globulin 1 cc inj | v1, posted September 15, 2026 |
| 1Q26 | $49.923 | +$0.89 | 1 CC | Gamma globulin 1 cc inj | v1, posted September 15, 2026 |
| 4Q25 | $49.033 | +$0.61 | 1 CC | Gamma globulin 1 cc inj | v1, posted September 8, 2026 |
| 3Q25 | $48.423 | −$0.462 | 1 CC | Gamma globulin 1 cc inj | v1, posted March 10, 2026 |
| 2Q25 | $48.885 | −$0.531 | 1 CC | Gamma globulin 1 cc inj | v1, posted March 10, 2026 |
| 1Q25 | $49.416 | −$0.436 | 1 CC | Gamma globulin 1 cc inj | v1, posted December 19, 2025 |
| 4Q24 | $49.852 | −$0.219 | 1 CC | Gamma globulin 1 cc inj | v1, posted June 11, 2025 |
| 3Q24 | $50.071 | +$1.01 | 1 CC | Gamma globulin 1 cc inj | v1, posted June 11, 2025 |
| 2Q24 | $49.061 | −$1.665 | 1 CC | Gamma globulin 1 cc inj | v1, posted March 11, 2025 |
| 1Q24 | $50.726 | +$1.96 | 1 CC | Gamma globulin 1 cc inj | v1, posted December 19, 2024 |
| 4Q23 | $48.766 | +$0.301 | 1 CC | Gamma globulin 1 cc inj | v1, posted October 10, 2024 |
| 3Q23 | $48.465 | +$0.146 | 1 CC | Gamma globulin 1 cc inj | v1, posted June 5, 2024 |
| 2Q23 | $48.319 | +$0.449 | 1 CC | Gamma globulin 1 cc inj | v1, posted February 23, 2024 |
| 1Q23 | $47.87 | +$1.114 | 1 CC | Gamma globulin 1 cc inj | v1, posted December 6, 2023 |
| 4Q22 | $46.756 | +$0.592 | 1 CC | Gamma globulin 1 cc inj | v1, posted June 22, 2023 |
| 3Q22 | $46.164 | −$0.263 | 1 CC | Gamma globulin 1 cc inj | v1, posted June 9, 2023 |
| 2Q22 | $46.427 | +$1.008 | 1 CC | Gamma globulin 1 cc inj | v1, posted December 14, 2022 |
| 1Q22 | $45.419 | +$1.288 | 1 CC | Gamma globulin 1 cc inj | v1, posted June 8, 2022 |
| 4Q21 | $44.131 | +$0.752 | 1 CC | Gamma globulin 1 cc inj | v1, posted June 2, 2022 |
| 3Q21 | $43.379 | +$0.203 | 1 CC | Gamma globulin 1 cc inj | v1, posted June 2, 2022 |
| 2Q21 | $43.176 | −$0.12 | 1 CC | Gamma globulin 1 cc inj | v1, posted March 1, 2022 |
| 1Q21 | $43.296 | – | 1 CC | Gamma globulin 1 cc inj | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.